Publication Date:
2014-02-07
Description:
Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model Gene Therapy 21, 131 (February 2014). doi:10.1038/gt.2013.63 Authors: C Weber, I Neacsu, B Krautz, P Schlegel, S Sauer, P Raake, J Ritterhoff, A Jungmann, A B Remppis, M Stangassinger, W J Koch, H A Katus, O J Müller, P Most & S T Pleger
Keywords:
heart failureDNA-based therapyS100A1AAVtherapeutic windowtranslational science
Print ISSN:
0969-7128
Electronic ISSN:
1476-5462
Topics:
Biology
,
Medicine
Permalink